8-KItem 5.02 · Officer/Director Change
Colgate-Palmolive ($CL) elected Christopher S.
Filed with the SEC on · Summarized by InvestorsBot
Colgate-Palmolive ($CL) elected Christopher S. Boerner (55) to its Board, effective Mar 15, 2026. Boerner is CEO (since Nov 2023) and Board Chair (since Apr 2024) of Bristol Myers Squibb ($BMY). He’ll receive Colgate’s non‑employee director pay per proxy (3/26/2025). 📌💼 #BoardAppointment #Colgate
Steven A. Cahillane told Colgate ($CL) he will not stand for reelection at the Annual Meeting on May 8, 2026, due to the demands of his new role as CEO of The Kraft Heinz Company ($KHC). 📅⚠️ #BoardChange #CorporateGovernance